Surrozen, Inc..
SRZN.US | Research and experimental development on natural sciences and engineering
Surrozen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel regenerative medicines to treat diseases with significant unmet medical needs. The company is pioneering the development of targeted therapeutics that selectively activate and harness the body's e...Show More
Better Health for All
0
Surrozen's core business is entirely devoted to developing novel regenerative medicines for severe liver and retinal diseases with high unmet medical needs, aiming to transform patient outcomes.
1
As a pre-clinical company, it has no products on the market and therefore generates no revenue from harmful products. In terms of safety, the SZN-1326 trial was voluntarily paused due to Grade 3 liver enzyme elevations in several subjects, and similar Grade 1 and 2 elevations were observed in the SZN-043 trial, although no serious adverse events were reported and elevations resolved spontaneously.
2
The company's products are in early development, so there is no evidence yet of direct impact on vulnerable populations or specific addiction mitigation programs. Surrozen voluntarily paused a trial and announced the decision, and discusses risks in SEC filings, but comprehensive public health information on risks is not evidenced.
3
The company is pioneering Wnt-based therapeutics and has a strategic partnership with Boehringer Ingelheim, receiving an upfront payment of $12.5 million and potential milestones up to $587.0 million, indicating significant investment in health innovation.
4
The voluntary pause of a trial due to adverse events, despite no serious adverse events, suggests improving rather than strong ethical standards for clinical trials.
Fair Money & Economic Opportunity
0
No evidence available to assess Surrozen, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
10
Surrozen's CEO compensation in 2023 was $1,165,250, and the median employee salary was $97,426.5, resulting in a pay ratio of approximately 11.96:1.
1
As of March 3, 2025, none of Surrozen's 41 employees are represented by a labor union or covered by collective bargaining agreements.
2
The company's overall employee rating on Glassdoor is 4.3 out of 5 stars, with 92% of employees recommending the company to a friend and a 91% positive business outlook.
3
However, some employee reviews mention a high turnover rate, with one review from November 2022 stating that some groups experienced high turnover.
4
While health benefits are mentioned qualitatively as 'excellent' and 'above average' in some reviews, and the company offers medical benefits, no specific percentage of employees covered by employer-funded health insurance is provided.
5
Fair Trade & Ethical Sourcing
0
No specific, quantitative evidence was found in the provided articles for SRZN.US regarding fair trade certifications, supplier audit frequency, forced or child labor incidents, supply chain traceability, remediation speed for violations, ethical clause coverage in supplier contracts, materials risk index, or supplier diversity spend.
1
The available information pertains to the company's internal Code of Business Conduct and Ethics and general ethical principles for its employees, officers, and directors, rather than concrete data on its supply chain practices or supplier performance against ethical sourcing criteria.
2
Honest & Fair Business
-40
The company has a Whistleblower Policy for accounting and auditing matters, providing a Toll-Free Hotline and a web form for anonymous reporting, with calls handled by a trained third-party vendor.
1
It explicitly prohibits retaliation against those who report in good faith.
2
Training on the Financial Conflict of Interest Policy is required at least every four years,
3
and periodic training is provided for the Code of Business Conduct and Ethics,
4
which includes the whistleblower policy. The company must complete a retrospective review of an Investigator's activities within 120 days of determining non-compliance with the Financial Conflict of Interest Policy.
5
The Board is composed of not less than a majority of independent directors, and the Audit, Compensation, and Nominating and Corporate Governance Committees are entirely independent, subject to Nasdaq listing standards.
6
The company has an Anti-Corruption Policy and mentions compliance with the U.S. Foreign Corrupt Practices Act,
7
but training frequency and effectiveness metrics for this policy are not specified.
Kind to Animals
-60
Surrozen, Inc. conducts animal experiments in accordance with approved IACUC protocols at both Stanford University and Surrozen, Inc., and adheres to national ethical guidelines such as the Guide for the Care and Use of Laboratory Animals and the ARVO Statement.
1
The company uses cell-based assays, computational modeling, and transcriptomic analysis of human liver tissue in initial stages of research.
2
Annually, Surrozen uses between 15,000 and 25,000 animals in its testing, with small year-on-year declines. The company has no formal collaborations related to animal-free R&D and minimal engagement with animal welfare stakeholders. There is no public position on animal welfare legislation.
No War, No Weapons
0
No evidence available to assess Surrozen, Inc. on No War, No Weapons.
Planet-Friendly Business
0
The provided articles focus on Surrozen's financial results, clinical development, and corporate partnerships, detailing financial data, clinical trial progress, and manufacturing collaborations. None of the articles contain any information or data related to environmental performance, such as carbon emissions, renewable energy use, waste management, water consumption, or any other planet-friendly business metrics.
1
Therefore, no KPIs can be scored.
Respect for Cultures & Communities
0
No specific, concrete data points were found in the provided articles that directly map to the quantitative thresholds or qualitative definitions of any KPI in the rubric for "Respect for Cultures & Communities". While Surrozen, Inc. raised $8,500 for the Crohn’s & Colitis Foundation, this activity does not align with the specific requirements of the KPIs, such as being a percentage of revenue, directed to local community development, or cultural heritage organizations.
1
Safe & Smart Tech
0
No specific data or evidence related to Surrozen, Inc.'s performance on any 'Safe & Smart Tech' KPIs was found in the provided articles.
1
The articles primarily describe financial data viewers or list companies without specific cybersecurity or privacy details for SRZN.US.
2
Zero Waste & Sustainable Products
0
No specific, concrete data points were found in the provided articles regarding Surrozen, Inc.'s performance across any of the Zero Waste & Sustainable Products KPIs. The articles discuss general industry practices, third-party solutions, or explicitly state they do not contain data specific to Surrozen, Inc.